Trial Profile
A Randomized, Double Blind, Placebo-controlled Phase II Study of KPS-0373 in Patients With SCD.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2012
Price :
$35
*
At a glance
- Drugs Rovatirelin (Primary)
- Indications Spinocerebellar degeneration
- Focus Therapeutic Use
- 30 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClincialTrials.gov record.
- 12 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Jul 2011 New trial record